Anti-VEGF Advances in Retina análises de aplicativos para 26 de julho

This Immersive Enhanced Reality experience investigates the role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME), neovascular age-related macular degeneration (nAMD), and retinal vein occlusion (RVO). The program presents management options for retinal disease, optimizing anti-VEGF treatment regimens through dosing strategies and next-generation anti-VEGF therapies to reduce treatment burden, and optimize outcomes in patients with these retinal conditions.